incretin mimetic agents glp 1 receptor agonists PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: GLP-1 Incretin - an overview |

Upon subgroup analysis, they observed a lower risk of mortality associated with the use of GLP-1 receptor agonists compared with DDP-4 inhibitors among patients with cerebrovascular disease (HR, 0.33) than among those without the cerebrovascular disease (HR, 0.89)

Consumer preferences are making hospitals rethink their weight loss programs, Marmolejos said

Others mean switching from one GLP-1 agonist to another

Ozempic, Mounjaro, and Wegovy have become household names, and as demand for these drugs and their competitors rises, their effects will only become more widespread

Aiming for 7 to 9 hours of quality sleep per night supports the hard work done in the gym

While the anti-inflammatory properties of GLP-1 therapy are promising, clinicians should counsel patients that definitive evidence for direct joint pain relief independent of weight loss is lacking